Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 4, 2025 in Revance Lawsuit - RVNC
Portfolio Pulse from
Levi & Korsinsky, LLP has announced a class action lawsuit against Revance Therapeutics, Inc. (NASDAQ: RVNC) for alleged securities fraud affecting investors between February 29, 2024, and December 6, 2024. The lead plaintiff deadline is March 4, 2025.
February 18, 2025 | 11:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Revance Therapeutics is facing a class action lawsuit for alleged securities fraud, potentially impacting its stock price. The lawsuit covers investors affected between February 29, 2024, and December 6, 2024.
The announcement of a class action lawsuit for alleged securities fraud is likely to negatively impact Revance's stock price in the short term as it raises concerns about the company's legal and financial standing.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100